Competitive Landscape of COVID-19 Therapies

Evaluation of COVID-19 Developmental Pipeline Therapies
Objective :

COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.

Problem Statement:

A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.

Our Methodology:
  • Therapeutic R&D Developmental Pipeline Assessment
  • Assessment of the Drugs
  • Key Pharmaceuticals Portfolio Assessment
  • Strategic Planning Assistance
  • Detailed profiling of Active Products in the Pipeline
  • Landscape analysis of various Mechanisms of Action and Routes of Administration
  • Matrix Analysis positioned the top 10 Companies researched.
  • The client can appraise all the top companies that can serve as a potential competition

Related Insights

Market Assessment
Market Assessment

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new class of drug showed the potential in targeting multiple... [...]

View Case
Asset Prioritization
Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case
Epidemiology Assessment
Epidemiology Assessment

A client based in the US wanted the epidemiology assessment exercise to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.